Huadong Medicine Co., Ltd (SHE:000963)

Market Cap	71.01B
Revenue (ttm)	42.23B
Net Income (ttm)	3.56B
Shares Out	1.75B
EPS (ttm)	2.03
PE Ratio	19.97
Forward PE	16.60
Dividend	1.16 (2.87%)
Ex-Dividend Date	Jun 5, 2025

Volume	31,969,256
Average Volume	13,929,434
Open	39.84
Previous Close	40.58
Day's Range	39.84 - 42.66
52-Week Range	26.96 - 45.92
Beta	0.49
RSI	60.30
Earnings Date	Aug 20, 2025

About Huadong Medicine

Huadong Medicine Co., Ltd, together with its subsidiaries, engages in the wholesale and retail of pharmaceutical products in China and internationally. It operates through Pharmaceutical Industry, Pharmaceutical Business, Aesthetic Medicine, and Industrial Microbiology segments. The company distributes Chinese and western medicines, Chinese herbal medicines, and medical instruments; and immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical beauty field products, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 18,265
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000963

Financial Performance

In 2024, Huadong Medicine's revenue was 41.91 billion, an increase of 3.16% compared to the previous year's 40.62 billion. Earnings were 3.51 billion, an increase of 23.72%.